S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Akero Therapeutics (AKRO) Insider Trading & Ownership

$21.60
-0.19 (-0.87%)
(As of 04/17/2024 ET)

Akero Therapeutics (NASDAQ:AKRO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.69%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$11.28 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$19.09 M
Get AKRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Akero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AKRO Insider Buying and Selling by Quarter

Akero Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/1/2024Jonathan YoungCOOSell5,000$24.38$121,900.00  
3/4/2024Andrew ChengCEOSell75,000$32.87$2,465,250.00  
3/4/2024Catriona YaleInsiderSell20,646$35.49$732,726.54  
12/27/2023Jonathan YoungCOOSell5,414$24.00$129,936.00  
12/14/2023Andrew ChengCEOSell1,628$20.76$33,797.28  
12/14/2023Catriona YaleInsiderSell597$20.76$12,393.72  
12/14/2023Jonathan YoungCOOSell543$20.76$11,272.68  
12/14/2023William Richard WhiteCFOSell611$20.76$12,684.36  
12/11/2023Andrew ChengCEOSell7,405$20.02$148,248.10  
12/8/2023Andrew ChengCEOSell12,873$20.01$257,588.73  
12/8/2023G. Walmsley GrahamDirectorBuy100,000$19.83$1,983,000.00  
11/30/2023G. Walmsley GrahamDirectorBuy50,000$16.90$845,000.00  
11/17/2023Jonathan YoungCOOSell30,000$14.68$440,400.00  
10/2/2023Andrew ChengCEOSell25,000$47.91$1,197,750.00  
10/2/2023Jonathan YoungCOOSell490$51.10$25,039.00  
9/21/2023Catriona YaleInsiderSell5,000$48.07$240,350.00  
9/13/2023Andrew ChengCEOSell1,682$50.34$84,671.88  
9/13/2023Catriona YaleInsiderSell617$50.34$31,059.78  
9/13/2023Jonathan YoungCOOSell562$50.34$28,291.08  
9/13/2023William Richard WhiteCFOSell632$50.34$31,814.88  
9/1/2023Andrew ChengCEOSell25,000$49.77$1,244,250.00  
8/28/2023Catriona YaleInsiderSell5,745$49.99$287,192.55  
8/8/2023G. Walmsley GrahamDirectorBuy25,000$42.06$1,051,500.00  
8/1/2023G. Walmsley GrahamDirectorBuy25,000$43.26$1,081,500.00  
7/28/2023G. Walmsley GrahamDirectorBuy30,000$42.69$1,280,700.00  
7/3/2023Andrew ChengCEOSell25,000$44.88$1,122,000.00  
6/23/2023Catriona YaleInsiderSell11,000$50.76$558,360.00  
6/21/2023Catriona YaleInsiderSell11,349$52.26$593,098.74  
6/20/2023William Richard WhiteCFOSell20,777$55.00$1,142,735.00  
6/16/2023Timothy RolphInsiderSell78,200$54.78$4,283,796.00  
6/16/2023Tomas J. HeymanDirectorSell26,000$54.67$1,421,420.00  
6/13/2023Andrew ChengCEOSell1,613$55.16$88,973.08  
6/13/2023Jonathan YoungCOOSell538$55.16$29,676.08  
6/13/2023Timothy RolphInsiderSell509$55.16$28,076.44  
6/13/2023William Richard WhiteCFOSell606$55.16$33,426.96  
6/1/2023Andrew ChengCEOSell25,000$45.10$1,127,500.00  
5/19/2023G. Walmsley GrahamDirectorBuy120,000$42.00$5,040,000.00  
5/1/2023Andrew ChengCEOSell25,000$45.07$1,126,750.00  
(Data available from 1/1/2013 forward)

AKRO Insider Trading Activity - Frequently Asked Questions

Who is on Akero Therapeutics's Insider Roster?

The list of insiders at Akero Therapeutics includes Andrew Cheng, Catriona Yale, G. Walmsley Graham, Jonathan Young, Kevin Bitterman, Seth Loring Harrison, Skorpios Trust, Timothy Rolph, Tomas J. Heyman, and William Richard White. Learn more on insiders at AKRO.

What percentage of Akero Therapeutics stock is owned by insiders?

9.69% of Akero Therapeutics stock is owned by insiders. Learn more on AKRO's insider holdings.

Which Akero Therapeutics insiders have been buying company stock?

The following insider purchased AKRO shares in the last 24 months: G. Walmsley Graham ($11,281,700.00).

How much insider buying is happening at Akero Therapeutics?

Insiders have purchased a total of 350,000 AKRO shares in the last 24 months for a total of $11,281,700.00 bought.

Which Akero Therapeutics insiders have been selling company stock?

The following insiders have sold AKRO shares in the last 24 months: Andrew Cheng ($16,392,179.07), Catriona Yale ($4,410,231.33), Jonathan Young ($2,444,715.12), Seth Loring Harrison ($3,482,566.52), Skorpios Trust ($71,166,000.00), Timothy Rolph ($7,374,976.73), Tomas J. Heyman ($1,421,420.00), and William Richard White ($2,945,246.44).

How much insider selling is happening at Akero Therapeutics?

Insiders have sold a total of 2,588,346 Akero Therapeutics shares in the last 24 months for a total of $109,637,335.21 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:AKRO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners